Prediction Case File
YouTubeEvaluation Complete

Friends! In this video, im going to discuss my 3 mistakes and what I learned from them.

1 extracted signal · 1 resolved · 0 still active

The Patient Investor profile imageThe Patient Investor28 Nov 2025, 01:28 UTC
Video preview for Friends! In this video, im going to discuss my 3 mistakes and what I learned from them.
Signals
1
Eligible signals in this source
Open
0
Still being tracked
Resolved
1
Evaluable outcomes
Successful
1
Canonical correct result
Failed
0
Canonical failed result
Resolved success
100%
Open and excluded signals omitted
Source overview

AI-generated source summary

The analysis identifies 3 mistakes in financial investments. First one is related with WBD, bought in late 2022. The video shares a personal experience of loss, attributable to merger between Warner Bros and Discovery, leading to a 27% loss when exiting the position around $21-$22. The fundamental reasoning based on pro forma revenue numbers was flawed because Warner Brothers numbers were wrong. The mistake in early 2023 was to trust over the CFO numbers. The presenter advises retail investors to avoid pre-merger investment setups. Second mistake relates to selling apple stock and also the risk of not buying stocks during the dip. The presenter advice in general to trim the portion and not sell everything.

AI-generated summary based on the source content.

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  3. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

  4. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  5. Market predictions extracted

    1 eligible signal linked to this case.

  6. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

Extracted intelligence

Signals in this source

Continue the evidence trail
Analyst history

The Patient Investor

Tracked signals
292
Historical success
32.9%
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.